Evidence map›Paper›PMID 29721216›Full record

ArticleOncotarget2018

Correction: Niclosamide and its analogs are potent inhibitors of Wnt/β-catenin, mTOR and STAT3 signaling in ovarian cancer.

Rebecca C Arend, Angelina I Londoño-Joshi, Abhishek Gangrade, Ashwini A Katre, Chandrika Kurpad, Yonghe Li, Rajeev S Samant, Pui-Kai Li, Charles N Landen, Eddy S Yang and 5 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Oncotarget, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. TMEM16 proteins: CaInternational journal of molecular medicine · 2024
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors.

Rebecca C ArendUniversity of Alabama at Birmingham, Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Birmingham, AL, USA.
Angelina I Londoño-JoshiUniversity of Alabama at Birmingham, Department of Radiation Oncology, Birmingham, AL, USA.
Abhishek GangradeUniversity of Alabama at Birmingham, Department of Radiation Oncology, Birmingham, AL, USA.
Ashwini A KatreUniversity of Alabama at Birmingham, Department of Radiation Oncology, Birmingham, AL, USA.
Chandrika KurpadUniversity of Alabama at Birmingham, Department of Radiation Oncology, Birmingham, AL, USA.
Yonghe LiSouthern Research Institute, Department of Oncology, Birmingham, AL, USA.
Rajeev S SamantUniversity of Alabama at Birmingham, Department of Pathology, Division of Molecular & Cellular Pathology, Birmingham, AL, USA.
Pui-Kai LiOhio State University, Department of Medicinal Chemistry and Pharmacognosy, Columbus, OH, USA.
Charles N LandenUniversity of Virginia, Department of Oncology, Division of Gynecologic Oncology, Charlottesville, VA, USA.
Eddy S YangUniversity of Alabama at Birmingham, Department of Radiation Oncology, Birmingham, AL, USA.
Bertha HidalgoUniversity of Alabama at Birmingham, Department of Epidemiology, Birmingham, AL, USA.
Ronald D AlvarezUniversity of Alabama at Birmingham, Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Birmingham, AL, USA.
John Michael StraughnUniversity of Alabama at Birmingham, Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Birmingham, AL, USA.
Andres ForeroUniversity of Alabama at Birmingham, Department of Medicine, Division of Hematology & Oncology, Birmingham, AL, USA.
Donald J BuchsbaumUniversity of Alabama at Birmingham, Department of Radiation Oncology, Birmingham, AL, USA.

Funding

University of Alabama at Birmingham's Diabetes Research CenterP30DK079626 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Kirk Michael Habegger · 2013 to 2026
$19.5M
NIDDK NIH HHS P30 DK079626
6 · The paper itself

Abstract

[This corrects the article DOI: 10.18632/oncotarget.13466.].

Identifiers

PMID29721216
PMCPMC5922410

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.